site stats

Crsp analyst ratings

WebApr 11, 2024 · View CRSP analyst ratings or view top-rated stocks. What is CRISPR Therapeutics' stock price forecast for 2024? 18 Wall Street analysts have issued 12-month price objectives for CRISPR … Web23 hours ago · Cantor Fitzgerald initiated coverage on CRISPR Therapeutics AG (NASDAQ:CRSP) with an Overweight rating and a price target of $72, citing an interesting gene editing play for 2024. The company...

CRISPR Therapeutics Is an Interesting

Web20 hours ago · Cathie Wood Buys CRSP Stock Before Cantor Price Target Initiation Cantor analyst Olivia Brayer has initiated coverage of Crispr with an “overweight” rating and a … Web2 days ago · The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 105.3% upside in the stock. While this highly sought-after metric has not … january 1 is what national day https://readysetbathrooms.com

CRISPR Therapeutics AG Common Shares (CRSP) Analyst Research

WebApr 13, 2024 · Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, CRISPR Therapeutics has a consensus rating of “Hold” and a consensus target price of $72.84. CRISPR Therapeutics Profile ( Get Rating) Web2 days ago · The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 105.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ... WebApr 14, 2024 · InvestorsObserver is giving Crispr Therapeutics AG (CRSP) an Analyst Rating Rank of 33, meaning CRSP is ranked higher by analysts than 33% of stocks. The average price target for CRSP is $87.24 and analyst’s rate the stock as a Buy. Wall Street analysts are rating CRSP a Buy today. Find out what this means to you and get the rest … january 1 new year\\u0027s day

Analyst Ratings for CRISPR Therapeutics Markets Insider

Category:CRISPR Therapeutics AG (CRSP) - Stock Analysis

Tags:Crsp analyst ratings

Crsp analyst ratings

CRISPR Therapeutics AG Research & Ratings CRSP Barron

Web2 days ago · View real-time CRSP stock price and news, along with industry-best analysis. ... Analyst Ratings. Average price target from 29 ratings: $78.76. ... Fundamental … WebApr 10, 2024 · According to 35 stock analysts, the average 12-month stock price forecast for CRSP stock is $ 85.88 , which predicts an increase of 89.16%. The lowest target is $ …

Crsp analyst ratings

Did you know?

WebMar 21, 2024 · Two analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $74.59. CRISPR Therapeutics Price Performance WebApr 3, 2024 · Crispr Therapeutics AG (CRSP) In a report released today, Anthony Butler from EF Hutton reiterated a Buy rating on Crispr Therapeutics AG, with a price target of $75.00. The company’s shares ...

WebCURLF Curaleaf Holdings Inc. Analyst Estimates & Rating – WSJ Curaleaf Holdings Inc. CURLF (U.S.: OTC) View All companies AT CLOSE 3:59 PM EDT 04/06/23 $2.436 USD -0.094 -3.72% Volume... WebCRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations. ... Number Of Ratings: 27: FY Report Date: 12/2024: …

WebCRSP Analyst Ratings Moderate Buy 17 Ratings 9 Buy 7 Hold 1 Sell Based on 17 analysts giving stock ratings to Crispr Therapeutics AG in the past 3 months CRSP … Web23 hours ago · Shares of CRISPR Therapeutics (CRSP 16.31%) were up 15% Thursday morning, a day after a drug-pricing group said the company's single-dose therapy for …

Web23 hours ago · Shares of CRISPR Therapeutics ( CRSP 16.66%) were up 15% Thursday morning, a day after a drug-pricing group said the company's single-dose therapy for sickle cell disease (SCD) could be cost...

WebMay 17, 2024 · Analyst Ratings for CRISPR Therapeutics. Benzinga. May. 17, 2024, 12:03 PM. Over the past 3 months, 11 analysts have published their opinion on CRISPR … january 1 new year calendarWeb1 day ago · CRISPR Therapeutics (CRSP) jumped Thursday after Cantor Fitzgerald launched its coverage with an Overweight rating and a $72 per share target. Find out the reasons. january 1 new year\u0027s dayWebApr 10, 2024 · The latest price target for CRISPR Therapeutics ( NASDAQ: CRSP) was reported by Bernstein on Tuesday, March 21, 2024. The analyst firm set a price target … lowest speed for streaming netflixWebCRSP CRISPR Therapeutics AG Analyst Estimates & Rating – WSJ CRISPR Therapeutics AG CRSP (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT … january 1 national holiday who declaredWebApr 10, 2024 · According to 33 stock analysts, the average 12-month stock price forecast for CRSP stock is $ 88.13 , which predicts an increase of 94.85%. The lowest target is $ 39.39 and the highest is $ 231. On average, analysts rate CRSP stock as a buy. Analyst Consensus: Buy Analyst Ratings january 1 national holiday firstWeb1 day ago · CRISPR Therapeutics (CRSP) jumped Thursday after Cantor Fitzgerald launched its coverage with an Overweight rating and a $72 per share target. Find out … lowest speed pokemon 2017WebAnalyst Ratings Average price target from 28 ratings: $ 86.40 Average score: Sell Under Hold Over Buy Full Ratings Open $45.63 Previous Close- YTD Change 12.52% 12 Month Change -32.63% Day... lowest speed wind turbine 2019